Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 929 | 0 | 0 | 0 | 0 |
| Gross Profit | 929 | N/A | N/A | N/A | N/A |
| Operating Expenses | 44,789 | 42,192 | 31,925 | 32,540 | 23,502 |
| Operating Income | -43,860 | -42,192 | -31,925 | -32,540 | -23,502 |
| Other Income | -1,330 | 1,246 | 1,759 | 1,203 | 753 |
| Pre-tax Income | -45,190 | -40,946 | -30,166 | -31,337 | -22,749 |
| Net Income Continuous | -45,190 | -40,946 | -30,166 | -31,337 | -22,749 |
| Net Income | $-45,190 | $-40,946 | $-30,166 | $-31,337 | $-22,749 |
| EPS Basic Total Ops | -0.79 | -0.84 | -0.62 | 7.64 | -0.47 |
| EPS Basic Continuous Ops | -0.79 | -0.84 | -0.62 | 7.65 | -0.47 |
| EPS Diluted Total Ops | -0.79 | -0.84 | -0.62 | 7.64 | -0.47 |
| EPS Diluted Continuous Ops | -0.79 | -0.84 | -0.62 | 7.65 | -0.47 |
| EBITDA(a) | $-43,260 | $-41,043 | $-30,681 | $-31,328 | $-22,678 |